The magnitude of the problem of chronic diseases (NCDs) in India is substantial and is growing

By EP News Bureau on November 7, 2014

Related Posts

Panel Discussion: Moving up the value chain without losing volume advantage

Dr Huzaifa Shabbir Choonia, Director and Head, Drug Substance-MSAT, OneSource

Mr Markus Obkircher, Director, Head of Customer Solutions R&D, Chemistry, Merck KGaA

Dr Rakesh Bhasin, Head R&D (Formulations), Biocon

Panel Discussion: Bengaluru: An emerging global innovation gateway

Mr Loganathan S, Associate VP, Onesource Biopharma

Ms Drashti Vyas, Marketing Manager, Sun Teknovation & Mr Vijay Kumar, Regional Manager-South, Sun Teknovation
Comments (0)
Add Comment